患者管理:妊娠期甲状旁腺疾病的管理
妊娠期甲状旁腺疾病的管理需考虑骨与矿物质代谢的生理性改变,诊断与治疗显著不同于非妊娠人群。高钙性原发性甲状旁腺功能亢进症(PHPT)宜在妊娠前经甲状旁腺切除术治愈,妊娠期如需手术优先在第二孕期进行;较轻病例推荐保守治疗,以水化为主,药物治疗证据有限。甲状旁腺功能减退症女性如管理得当,妊娠并发症风险低,但需定期主动监测,产后及哺乳期应继续监测,新生儿需根据疾病严重程度监测钙水平。
要点
- 高钙性PHPT孕妇的母胎妊娠并发症似乎随高钙血症程度增加,PHPT宜在妊娠前经甲状旁腺切除术治愈。
- 妊娠期如需甲状旁腺切除术,优先在第二孕期进行;较轻病例推荐保守治疗,以水化为主。
- 甲状旁腺功能减退症女性如管理得当,妊娠并发症风险低,但需定期主动监测,产后及哺乳期继续监测。
核心结论
- 妊娠期甲状旁腺疾病的管理需考虑骨与矿物质代谢的生理性改变,诊断与治疗显著不同于非妊娠人群。
- 高钙性PHPT孕妇的母胎妊娠并发症似乎随高钙血症程度增加,PHPT宜在妊娠前经甲状旁腺切除术治愈。
- 甲状旁腺功能减退症女性如管理得当,妊娠并发症风险低,但需定期主动监测。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- 高钙性PHPT孕妇的母胎妊娠并发症似乎随高钙血症程度增加。
- 妊娠期如需甲状旁腺切除术,优先在第二孕期进行。
- 甲状旁腺功能减退症女性如管理得当,妊娠并发症风险低。
- 妊娠期对钙和活性维生素D的需求可能朝任一方向变化,总体趋势为剂量偏降低。
- 产后高钙血症风险增加。
关键数值与推荐
- 较轻PHPT病例推荐保守治疗,以水化为主,药物治疗证据有限。
- 甲状旁腺功能减退症女性推荐定期主动监测。
- 妊娠期甲状旁腺疾病女性需在产后及哺乳期进一步监测。
- 新生儿应根据疾病严重程度在出生后数天(至数周)监测钙水平。
临床怎么用
- PHPT宜在妊娠前经甲状旁腺切除术治愈。
- 妊娠期如需甲状旁腺切除术,优先在第二孕期进行。
- 较轻PHPT病例推荐保守治疗,以水化为主。
- 甲状旁腺功能减退症女性推荐定期主动监测。
- 妊娠期甲状旁腺疾病女性需在产后及哺乳期进一步监测,新生儿根据疾病严重程度监测钙水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Taking care of patients with parathyroid disorders during pregnancy requires consideration of the physiological fundamental changes in bone and mineral metabolism occurring in these women. Diagnostic and therapeutic procedures regarding primary hyperparathyroidism (PHPT) and hypoparathyroidism significantly differ from the nonpregnant population. PHPT should preferably be cured by parathyroidectomy before pregnancy since in women with hypercalcemic PHPT, maternal and fetal pregnancy complications seem to increase according to the degree of hypercalcemia. Parathyroidectomy, if needed during pregnancy, is preferentially performed in the second trimester. Conservative treatment is recommended for milder cases and is mainly restricted to hydration, with only limited evidence regarding drug treatment. Women with hypoparathyroidism can be informed that there are no major concerns regarding disease-associated infertility and that the risk of pregnancy complications is low if the disease is properly managed. Regular active surveillance is recommended, as requirements for calcium and active vitamin D may change during the course of pregnancy in either direction, with an overall trend for rather reduced doses. Any woman suffering from parathyroid disorders during pregnancy requires further surveillance in the postpartum period and during lactation, as there is an increased risk of hypercalcemia after delivery. Newborns of mothers with parathyroid diseases should, depending on disease severity, be carefully monitored for calcium levels in the first days (to weeks) after delivery since intrauterine exposure to hyper- or hypocalcemia may impact their postnatal regulation of calcium metabolism.
引用
- Appelman-Dijkstra NM, Pilz S. Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy. J Clin Endocrinol Metab. 2023. PMID: 36546344. doi:10.1210/clinem/dgac734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。